metformin has been researched along with Adult Premature Aging Syndrome in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diabetes associated with Werner syndrome is classified as "accompanied with other diseases and conditions and the one occurring mainly in association with other genetic syndromes." | 1.62 | Management guideline for Werner syndrome 2020. 3. Diabetes associated with Werner syndrome. ( Kato, H; Koshizaka, M; Kubota, Y; Kuzuya, M; Maezawa, Y; Mori, S; Motegi, SI; Nakagami, H; Takemoto, M; Taniguchi, A; Taniguchi, T; Tsukamoto, K; Yokote, K, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takemoto, M | 1 |
| Kubota, Y | 1 |
| Taniguchi, T | 1 |
| Motegi, SI | 1 |
| Taniguchi, A | 1 |
| Nakagami, H | 1 |
| Maezawa, Y | 1 |
| Koshizaka, M | 1 |
| Kato, H | 1 |
| Tsukamoto, K | 1 |
| Mori, S | 1 |
| Kuzuya, M | 1 |
| Yokote, K | 1 |
| Guillín-Amarelle, C | 1 |
| Sánchez-Iglesias, S | 1 |
| Araújo-Vilar, D | 1 |
1 review available for metformin and Adult Premature Aging Syndrome
| Article | Year |
|---|---|
[Uncommon lipodystrophic syndromes].
Topics: Acro-Osteolysis; Adipose Tissue; Aging, Premature; Body Composition; Cardiovascular System; Combined | 2015 |
1 other study available for metformin and Adult Premature Aging Syndrome
| Article | Year |
|---|---|
Management guideline for Werner syndrome 2020. 3. Diabetes associated with Werner syndrome.
Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Metformi | 2021 |